Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Qianhui Pharmaceutical is a comprehensive pharmaceutical enterprise based in Taiyuan, China, specializing in the research, development, production, and sale of various medicinal products. The company's portfolio includes a wide range of formulations such as injections, tablets, capsules, and granules, with a strong focus on cardiovascular, anti-infective, and gastrointestinal therapeutic areas. One of its flagship products is the Ginkgo Biloba Extract Injection, which is widely used in the Chinese market for treating cerebral and peripheral blood flow disorders. Shanxi Qianhui operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality production. The company continues to expand its market presence through a robust distribution network across China and ongoing investment in product innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Qianhui Pharmaceutical.